Crinetics Pharmaceuticals Inc buy Citigroup Inc.
Start price
14.11.24
/
50%
€57.00
Target price
14.11.25
€70.14
Performance (%)
-36.14%
End price
15.11.25
€36.40
Summary
This prediction ended on 15.11.25 with a price of €36.40. Massive losses of -36.14% were the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.392% | 5.392% | -19.626% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Citigroup_Inc_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Citigroup Inc. from $70.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten